Apollo Care, Llc: Semaglutide 5mg (1mg/ml), Glycine 25 Mg (5mg/ml)
Recall Summary Apollo Care, LLC is recalling Semaglutide 5mg/1mL and Glycine 25mg/5mL injectable medication distributed nationwide because the vials contain foreign particles made of nylon/polyamide and silk-type material. This is a Class II recall, meaning the product could cause serious health problems or adverse effects. The affected product is NDC 71170-712-03, a 5mL multi-dose vial sold under the Apollo Care brand.
- Recalling firm
- Apollo Care, LLC
- Product
- SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03
- Reason
- Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-29
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the U.S
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/d488c008-b265-488b-8b89-7efa0c96d7c1